You are here

  • Home
  • Archive
  • Volume 67, Issue Suppl 2
  • P115 Induction Immunosuppression (IS) with Antithymocyte Globulin (ATG) Followed by Mycophenolic Acid (MPA) Significantly Reduces Risk of Acute Cellular Rejection (ACR) But May Increase the Risk of Post-Transplant Lymphoproliferative Disease (PTLD) Post …

Article info

Article menu

Download PDFPDF

Poster sessions
Mechanisms of chronic lung disease
P115 Induction Immunosuppression (IS) with Antithymocyte Globulin (ATG) Followed by Mycophenolic Acid (MPA) Significantly Reduces Risk of Acute Cellular Rejection (ACR) But May Increase the Risk of Post-Transplant Lymphoproliferative Disease (PTLD) Post Lung Transplantation (LTx)
Free

Authors

Citation

Al-Aloul M, Al-Skeklley B, Salaie J, et al
P115 Induction Immunosuppression (IS) with Antithymocyte Globulin (ATG) Followed by Mycophenolic Acid (MPA) Significantly Reduces Risk of Acute Cellular Rejection (ACR) But May Increase the Risk of Post-Transplant Lymphoproliferative Disease (PTLD) Post Lung Transplantation (LTx)
Thorax 2012;67:A112.

Publication history

  • First published November 19, 2012.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.